Abrahams Brett
Gründer bei Heppinn Biosciences
Profil
Abrahams Brett is the founder of Heppinn Biosciences, which was founded in 2020.
Currently, Dr. Brett serves as an advisory board member for Accelerator Services Corp, Foundation for Angelman Syndrome Therapeutics, and Cureshank.
Dr. Brett previously held positions as Senior Director at Ovid Therapeutics, Inc. in 2018 and as Executive Vice-President at Magnolia Neurosciences Corp.
from 2018 to 2022.
Dr. Brett received an undergraduate degree from Queen's University in 1997 and a doctorate degree from the University of British Columbia in 2004.
Aktive Positionen von Abrahams Brett
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Berater | 01.02.2022 |
| Heppinn Biosciences | Gründer | 01.11.2020 |
Foundation for Angelman Syndrome Therapeutics
 Foundation for Angelman Syndrome Therapeutics Miscellaneous Commercial ServicesCommercial Services The Foundation for Angelman Syndrome Therapeutics (FAST) is a non-governmental funding organization that supports research for Angelman syndrome. The non-profit company is based in Austin, TX. The organization is focused on finding prospective treatments for the syndrome. FAST Athletes is a program led by high-class athletes in the Angelman syndrome community who help support the mission of FAST. The company was founded in 2008 by Paula M. Evans. | Berater | 01.09.2022 |
| Cureshank | Berater | 01.09.2019 |
Ehemalige bekannte Positionen von Abrahams Brett
| Unternehmen | Position | Ende |
|---|---|---|
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Private Equity Investor | 28.02.2022 |
| OVID THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 30.08.2018 |
Ausbildung von Abrahams Brett
| Queen's University | Undergraduate Degree |
| University of British Columbia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
| Heppinn Biosciences | |
Foundation for Angelman Syndrome Therapeutics
Foundation for Angelman Syndrome Therapeutics Miscellaneous Commercial ServicesCommercial Services The Foundation for Angelman Syndrome Therapeutics (FAST) is a non-governmental funding organization that supports research for Angelman syndrome. The non-profit company is based in Austin, TX. The organization is focused on finding prospective treatments for the syndrome. FAST Athletes is a program led by high-class athletes in the Angelman syndrome community who help support the mission of FAST. The company was founded in 2008 by Paula M. Evans. | Commercial Services |
| Cureshank | |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Health Technology |
